TrialAlzheimer's & dementia : the journal of the Alzheimer's Association2026

Longitudinal clinical outcomes after amyloid clearance in aducanumab phase 3 studies.

Menglan Pang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.